The American Cancer Society has partnered with Samsung and software startup Breezie to conduct a pilot program to offer breast cancer patients a single point of contact across their medical team, family and caregivers as well as to offer access to customized treatment and clinical trial information and an online support group.
Drug delivery device maker Unilife received a cash lifeline worth up to $75 million from Amgen. Amgen gains exclusive rights to the struggling York, PA, company's wearable injectors within selected drug classes and nonexclusive rights to all of Unilife's proprietary injectable delivery systems within the therapeutic areas of oncology, inflammation, bone health, nephrology, cardiovascular and neuroscience.
Contract drugmaker and delivery specialist Consort Medical has signed with eyecare company Precision Ocular to build up Precision's drug delivery system using Consort's device and manufacturing capabilities. As part of the deal, Consort joined a $19 million financing round for the U.K. startup.
Pronutria Biosciences in Cambridge, MA, has added a $42.5 million investment stake from Nestlé Health Science as it maps a route to late-stage research for its amino acid R&D; platform.
Private, family-owned orthopedics player Mathys is looking to add 3-D printed surgical shoulder guides as part of a larger effort to help it turn around its business. The Bettlach, Switzerland-based company will offer the Shoulder Guide System from Materialise, which is located in Leuven, Belgium.
Seoul-based GeneOne Life Sciences is working with Inovio Pharmaceuticals on preclinical efforts to develop a vaccine to the Zika virus in a second collaboration between the firms that also joined hands on a Middle East respiratory syndrome, or MERS, vaccine effort last year.
China's cabinet leadership State Council has said it wants to move intellectual property faster out of its elite research centers into commercial realms that allow developers to cash in, a move that fits with a rush of cash into biopharma plays that has captured attention.
A scant few months ago GE Healthcare disclosed a partnership with deep learning medical imaging startup Arterys, just as the San Francisco-based company nabbed a $7 million Series A investment. Now, GE is preparing to launch the resulting cardiac MR analysis system ViosWorks that offers a deep learning analysis of 7-dimensional cardiac imaging data.
Japanese biopharmaceutical company Sosei is seeking partners globally to make use of last year's $400 million acquisition of U.K. biotech company Heptares Therapeutics.
Royal Philips and Hitachi Data Systems will collaborate to develop a speedy, universal medical image management system that it expects will be on the market during the second half of this year.